Efficacy of First-Line Gemcitabine Chemotherapy in GemCore+ Metastatic Pancreatic Adenocarcinoma Patients
NCT06046794
·
clinicaltrials.gov ↗
NA
Phase
RECRUITING
Status
100
Enrollment
OTHER
Sponsor class
Conditions
Cancer Of Pancreas
Interventions
OTHER:
Analyze of GemCore status
Sponsor
Institut Paoli-Calmettes